| Application no. and date | 03751859.4 (espacenet) (Federated) (European Patent Register), 20030814 | | Patent/reg. no. and date | DK/EP 1542668, 20090415 | | Publication date | 20050622 | | Priority no. and date | US 404713 P, 20020820 | | EP pub. no. and date |
EP 1542668 20050622 | | Effective date | | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda-Tsukasamachi, Chiyoda-ku
Tokyo 101-8535, JP | | Applicant ref. no. | 6/09019-6 | | Inventor | NERURKAR, Manoj, 83 Regal Drive
Monmouth Junction, NJ 08852, US,
NARINGREKAR, Vijay, 538 Burlington St.
Paramus, NJ 07652, US,
DOMINICK, Mark, 10540 Wilmington Dr.
Evansville, IN 47725, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 47/12 (2006.01) , A61P 25/18 (2006.01) | | Title | Formulering af aripiprazolkompleks og fremgangsmåde | | Int. application no. | US2003025573 | | Int. publication no. | WO2004017897 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
